MA43132A - Compositions aqueuses de spironolactone - Google Patents

Compositions aqueuses de spironolactone

Info

Publication number
MA43132A
MA43132A MA043132A MA43132A MA43132A MA 43132 A MA43132 A MA 43132A MA 043132 A MA043132 A MA 043132A MA 43132 A MA43132 A MA 43132A MA 43132 A MA43132 A MA 43132A
Authority
MA
Morocco
Prior art keywords
spironolactone
aqueous compositions
compositions
aqueous
Prior art date
Application number
MA043132A
Other languages
English (en)
Inventor
Michael Paul Dehart
Anthony Pipho
Original Assignee
Cmp Dev Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58630885&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA43132(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cmp Dev Llc filed Critical Cmp Dev Llc
Publication of MA43132A publication Critical patent/MA43132A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
MA043132A 2015-10-30 2016-10-28 Compositions aqueuses de spironolactone MA43132A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562495583P 2015-10-30 2015-10-30

Publications (1)

Publication Number Publication Date
MA43132A true MA43132A (fr) 2018-09-05

Family

ID=58630885

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043132A MA43132A (fr) 2015-10-30 2016-10-28 Compositions aqueuses de spironolactone

Country Status (5)

Country Link
US (1) US9757394B2 (fr)
EP (1) EP3368045A4 (fr)
CA (1) CA3003028A1 (fr)
MA (1) MA43132A (fr)
WO (1) WO2017075463A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10493083B2 (en) * 2015-10-30 2019-12-03 Cmp Development Llc Spironolactone aqueous compositions
US12053447B2 (en) 2019-06-25 2024-08-06 NuBioPharma, LLC Oral solution and powder to liquid compositions of balsalazide
WO2022074528A1 (fr) * 2020-10-06 2022-04-14 Callidus Research Laboratories Limited Solution orale stable de spironolactone
CN118632687A (zh) * 2021-11-11 2024-09-10 阿尔库缇斯生物疗法股份有限公司 用于深层皮肤药物递送的螺内酯药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837211A (en) 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Spironolactone composition
GB0114532D0 (en) * 2001-06-14 2001-08-08 Jagotec Ag Novel compositions
WO2003004009A1 (fr) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Formulation a compression directe de medicaments faiblement compressibles tels que le chlorhydrate de metformine
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
EP1492511B3 (fr) * 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
GB2395124A (en) * 2002-11-16 2004-05-19 Fluid Technologies Plc Palatable microcapsules
JP2006511525A (ja) 2002-12-13 2006-04-06 ヤゴテック アーゲー ナノ粒子状スピロノラクトン局所製剤
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
WO2007086078A2 (fr) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Compositions pharmaceutiques atypiques et processus de preparation correspondant
US9585836B2 (en) * 2008-06-05 2017-03-07 Peter Quagliano Palatable liquid dilution vehicles for oral contrast agents
US20130039871A1 (en) * 2010-04-27 2013-02-14 Kao Corporation Aqueous composition contained in container
US9737609B2 (en) * 2014-08-20 2017-08-22 Professional Compounding Centers Of America (Pcca) Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Also Published As

Publication number Publication date
EP3368045A1 (fr) 2018-09-05
WO2017075463A1 (fr) 2017-05-04
CA3003028A1 (fr) 2017-05-04
EP3368045A4 (fr) 2019-08-07
US20170119796A1 (en) 2017-05-04
US9757394B2 (en) 2017-09-12

Similar Documents

Publication Publication Date Title
EP3297455A4 (fr) Compositions de glycoside
DK3361870T3 (da) Fungicidsammensætninger
PT3355990T (pt) Compostos semifluorados e as suas composições
HUE049233T2 (hu) C9ORF72-expresszió módosítására szolgáló készítmények
DK3099775T3 (da) Vandige detergentsammensætninger
EP3476002C0 (fr) Compositions aqueuses d'encre
EP3289026A4 (fr) Composition aqueuse de revêtement antitache
EP4218939C0 (fr) Compositions d'encre
EP3334726A4 (fr) Compositions de plinabuline
DK3250182T3 (da) Dispergible sammensætninger
PT3457851T (pt) Derivados de sobetiroma
DK3253485T3 (da) No-holdige sammensætninger
EP3337340A4 (fr) Solutions de glycoside de stéviol
DK3283210T3 (da) Fremgangsmåde
EP3388505A4 (fr) Composition de tensio-actif
EP3388504A4 (fr) Composition de tensio-actif
FR3023290B1 (fr) Derives de flavaglines
EP3328991A4 (fr) Biosynthèse de polycétides
LT3216451T (lt) Oftalmologinė vandeninė kompozicija
EP3397352A4 (fr) Compositions de déodorant
EP3277701A4 (fr) Synthèse de désosamines
DK3316857T3 (da) Multifasiske sammensætninger
PL3528791T3 (pl) Kompozycje dyspergowalne
MA43132A (fr) Compositions aqueuses de spironolactone
IL272670A (en) Preparation of micro-electrodes